Fortrea Holdings Inc (NAS:FTRE)
$ 20.7 +1.5 (+7.81%) Market Cap: 1.96 Bil Enterprise Value: 2.93 Bil PE Ratio: 0 PB Ratio: 3.72 GF Score: 65/100

Q4 2024 Fortrea Holdings Inc Earnings Call Transcript

Mar 03, 2025 / 02:00PM GMT
Release Date Price: $10.38 (-25.05%)

Key Points

Positve
  • Fortrea Holdings Inc (FTRE) achieved a strong book-to-bill ratio of 1.35 in the fourth quarter, indicating robust demand and successful sales efforts.
  • The company's backlog has grown to $7.7 billion, reflecting a solid pipeline of future work.
  • Fortrea's phase one clinical pharmacology services business experienced its most successful quarter ever, driven by significant repeat awards and investments in clinic capacity.
  • The company successfully exited most of its Transition Service Agreement with its former parent, reducing associated costs and improving operational independence.
  • Fortrea has implemented a comprehensive customer relationship feedback program, resulting in significantly improved net promoter scores, indicating enhanced customer satisfaction.
Negative
  • Fortrea's revenue and adjusted EBITDA projections for 2025 are below prior expectations due to the impact of pre-spin projects with lower revenue and profitability.
  • The company's fourth-quarter revenues declined by 1.8% year-over-year, primarily due to lower late-stage clinical service fee revenue.
  • SG&A expenses increased by 16.9% year-over-year, driven by professional fees and one-time costs related to exiting TSA services.
  • The adjusted EBITDA margin for full year 2024 decreased to 7.5% from 8.6% in 2023, impacted by lower late-stage clinical service fee revenues and higher SG&A costs.
  • Fortrea's net loss for full year 2024 was $271.5 million, a significant increase from the net loss of $31.7 million in 2023, highlighting financial challenges.
Operator

Ladies and gentlemen, thank you for standing by, and welcome to Fortrea fourth-quarter 2024 earnings conference call. (Operator Instructions) Please be advised that today's conference is being recorded.

I would like now to turn the conference over to Hima Inguva, Head of Investor Relations and Corporate Development. Please go ahead.

Hima Inguva Fortrea Inc.;Head of Investor Relations and Corporate Development

Good morning and thank you for joining Fortrea's fourth quarter 2024 earnings conference call. I am Hima Inguva, Head of Investor Relations and Corporate Development at Fortrea. On the call with me today are our CEO, Tom Pike and CFO, Jill McConnell. The call is being webcasted and the slides accompanying today's presentation have been posted to the Investor Relations page of our website, fotrea.com.

During this call, we'll make certain forward-looking statements within the meaning of Private Securities Litigation Reform Act of 1995. These statements are subject to significant risks and uncertainties that could cause actual

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot